Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) reported Q4 CY2024 results topping the market’s revenue ...

LNTH READ THE FULL LNTH RESEARCH REPORT Lantheus Holdings, Inc. (NASDAQ:LNTH) reported 2024 financial and operational results on February 26 th , producing sales of over $1 billion for Pylarify during ...

Q4 2024 Earnings Call Transcript February 26, 2025 Operator: Good morning. Welcome to the Lantheus Fourth Quarter and Full ...

Below is Validea's guru fundamental report for LANTHEUS HOLDINGS INC (LNTH). Of the 22 guru strategies we follow, LNTH rates highest using our Twin Momentum Investor model based on the published ...

Lantheus Holdings, Inc. ( NASDAQ:LNTH ) shareholders have seen the share price descend 19% over the month. But ...

Appointment of Dr. Phuong Khanh Morrow, an experienced pharmaceutical executive and physician-scientist, to the Board of Directors enhances Lantheus' leadership team. Dr. Morrow’s expertise in ...

Lantheus Holdings Inc (NASDAQ:LNTH) is set to release its Q4 2024 earnings on Feb 26, 2025. The consensus estimate for Q4 ...

Shares of radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) jumped 19.8% in the morning session after the company ...

Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) will be reporting earnings tomorrow before market hours. Here’s ...

Lantheus Holdings Inc (LNTH) reports robust sales growth for PYLARIFY and DEFINITY, while navigating increased operating ...

Three of IJK's underlying holdings with notable upside to their analyst target prices are Lantheus Holdings Inc (Symbol: LNTH), Weatherford International plc (Symbol: WFRD), and Matador Resources ...

Principal Financial Group Inc. reduced its position in shares of Lantheus Holdings, Inc. (NASDAQ:LNTH – Free Report) by 22.7% during the 4th quarter, according to the company in its most recent 13F ...